skip to main content
Idioma:
Mostrar Somente
Refinado por: autor: Reuter, T remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The New Cambridge Medieval History
The New Cambridge Medieval History
Material Type:
Livro 		Adicionar ao Meu Espaço

The New Cambridge Medieval History

Paul Fouracre; Timothy Reuter; David Luscombe; Jonathan Riley-Smith; Michael Jones

Cambridge England Cambridge University Press New York, NY, USA 1995-

Localização: FFLCH - Fac. Fil. Let. e Ciências Humanas    (940.1 C178 v.7 1998 )(Acessar)

2
HCV RNA <15 IU/mL at week 4 is highly predictive of SVR among HCV G2/3 patients receiving peginterferon alfa-2A/RBV final results from potente study
HCV RNA <15 IU/mL at week 4 is highly predictive of SVR among HCV G2/3 patients receiving peginterferon alfa-2A/RBV final results from potente study
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

HCV RNA <15 IU/mL at week 4 is highly predictive of SVR among HCV G2/3 patients receiving peginterferon alfa-2A/RBV final results from potente study

H. Cheinquer C. G. D. F Mendes; M. P. J. S Lima; M. L Ferraz; E. R Parise; F Ruiz; F. L Gonçalves Júnior; T Reuter; Maria Cássia Jacintho Mendes-Corrêa; A Ferreira; F. S. B. de Araújo; M. A Costa; Ana Lourdes Candolo Martinelli; E. G Marins; Annual Meeting of the European Association for the Study of the Liver (47. 2012 Barcelona)

Journal of Hepatology Amsterdam v. 56, p. S432, res. 1098, 2012

Amsterdam 2012

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2303824 estantes deslizantes ) e outros locais(Acessar)

3
The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil a multicentric study
The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil a multicentric study
Material Type:
Artigo 		Adicionar ao Meu Espaço

The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil a multicentric study

Paulo Roberto Abrão Ferreira Mariliza Henrique da Silva; Carlos Eduardo Brandão-Melo; Rosamar Eulira Rezende; Mário Gonzalez; Tânia Reuter; Jose David Urbaez; Reinaldo Jose Gianini; Ana Martinelli; Maria Cássia Mendes-Corrêa

Brazilian Journal of Infectious Diseases Salvador v. 19, n. 1, p. 15-22, 2015

Salvador 2015

Localização: FM - Fac. Medicina    (BCSEP 208 2015 )(Acessar)

4
Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial
Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial

Mitchell L. Shiffman Hugo Cheinquer; Christoph P Berg; Thomas Berg; Claudio de Figueiredo-Mendes; Gregory J Dore; Maria Lucia Ferraz; Maria Cassia Mendes-Correa; Maria Patelli Lima; Edison R Parise; Alma Minerva Perez Rios; Tania Reuter; Arun J Sanyal; Stephen D Shafran; Marc Hohmann; Fernando Tatsch; George Bakalos; Stefan Zeuzem

Hepatology International New York v. 8, n. 4, p. 517-526, 2014

New York 2014

Acesso online. A biblioteca também possui exemplares impressos.

5
Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil a multicenter study
Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil a multicenter study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil a multicenter study

Luciana Azevêdo Callefi Cristiane Alves Villela-Nogueira; Simone de Barros Tenore; Dimas Carnaúba-Júnior; Henrique Sérgio Moraes Coelho; Paulo de Tarso A Pinto; Letícia Cancella Nabuco; Mário Guimarães Pessôa; Maria Lúcia Cardoso Gomes Ferraz; Paulo Roberto Abrão Ferreira; Ana de Lourdes Candolo Martinelli; Silvana Gama Florencio Chachá; Adalgisa de Souza Paiva Ferreira; Alessandra Porto de Macedo Bisio; Carlos Eduardo Brandão-Mello; Mário Reis Álvares-da-Silva; Tania Reuter; Claudia Alexandra Pontes Ivantes; Renata de Mello Perez; Maria Cássia Jacintho Mendes-Côrrea

Clinics São Paulo v. 72, n. 6, p. 378-385, 2017

São Paulo 2017

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2917067 Estantes Deslizantes )(Acessar)

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (1)

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Reuter, T
  2. Ferraz, M
  3. Martinelli, A
  4. Parise, E
  5. Ferreira, P

Neste Assunto:

  1. VÍRUS DA HEPATITE C
  2. Interferons
  3. Hepatite C (Tratamento)
  4. Inibidores De Enzimas
  5. Doença Crônica

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.